We have located links that may give you full text access.
Pre-clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization.
OBJECTIVE: To evaluate the concept and efficacy of an adjustable implant (Prototype SH30: porcine implant and APrevent® VOIS: human concept) for treatment of unilateral vocal fold paralysis (UVFP) via in vivo mini-pig studies, human computed tomographic (CT) and magnetic resonance (MR) image analysis, ex-vivo aerodynamic and acoustic analysis.
METHODS: Feasibility testing and prototype implantation were performed using in-vivo UVFP porcine model ( n = 8), followed by a dimensional finding study using CT and MR scans of larynges ( n = 75) for modification of the implant prototypes. Acoustic and aerodynamic measurements were recorded on excised canine ( n = 7) larynges with simulated UVFP before and after medialization with VOIS-Implant.
RESULTS: The prototype showed in the in-vivo UVFP porcine model an improved glottic closure from grade 6 incomplete closure to complete closure ( n = 5), to grade 2 incomplete closure ( n = 2) and grade 3 incomplete closure ( n = 1). On human CT/MR scans the identification of the correct size was successful in 97.3% using the thyroid cartilage alar "distance S" as the only parameter, which is an important step towards procedure standardization and implant design. Results were confirmed with implantation in human laryngeal cadavers ( n = 44). Measurements of the acoustic and aerodynamic effects after implantation showed a significant decreased phonation threshold pressure ( p = .0187), phonation threshold flow ( p = .0001) and phonation threshold power ( p = .0046) on excised canine larynges with simulated UVFP. Percent jitter and percent shimmer decreased ( p = .2976; p = .1771) but not significant.
CONCLUSIONS: Based on the preclinical results four sizes, differing in medial length, implant width and expansion direction of silicone cushions, seem to be enough to satisfy laryngeal size variations. This concept is significantly effective in medializing UVFP and improving the aerodynamic and acoustic qualities of phonation as reported in a preliminary clinical outcome study with long-term implantation.
LEVEL OF EVIDENCE: N/A.
METHODS: Feasibility testing and prototype implantation were performed using in-vivo UVFP porcine model ( n = 8), followed by a dimensional finding study using CT and MR scans of larynges ( n = 75) for modification of the implant prototypes. Acoustic and aerodynamic measurements were recorded on excised canine ( n = 7) larynges with simulated UVFP before and after medialization with VOIS-Implant.
RESULTS: The prototype showed in the in-vivo UVFP porcine model an improved glottic closure from grade 6 incomplete closure to complete closure ( n = 5), to grade 2 incomplete closure ( n = 2) and grade 3 incomplete closure ( n = 1). On human CT/MR scans the identification of the correct size was successful in 97.3% using the thyroid cartilage alar "distance S" as the only parameter, which is an important step towards procedure standardization and implant design. Results were confirmed with implantation in human laryngeal cadavers ( n = 44). Measurements of the acoustic and aerodynamic effects after implantation showed a significant decreased phonation threshold pressure ( p = .0187), phonation threshold flow ( p = .0001) and phonation threshold power ( p = .0046) on excised canine larynges with simulated UVFP. Percent jitter and percent shimmer decreased ( p = .2976; p = .1771) but not significant.
CONCLUSIONS: Based on the preclinical results four sizes, differing in medial length, implant width and expansion direction of silicone cushions, seem to be enough to satisfy laryngeal size variations. This concept is significantly effective in medializing UVFP and improving the aerodynamic and acoustic qualities of phonation as reported in a preliminary clinical outcome study with long-term implantation.
LEVEL OF EVIDENCE: N/A.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app